This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
IQVIA (IQV) Announces Launch of Clinical Data Analytics Suite
by Zacks Equity Research
IQVIA's (IQV) new platform brings benefits such as real-time data management, reduced data-harmonization efforts, reduced time of KPI deployment and improved decision making.
IQVIA Holdings (IQV) Stock Up 55.4% Over a Year: Here's Why
by Zacks Equity Research
IQVIA Holdings (IQV) stock is riding on consecutive better-than-expected top- and bottom-line performances, and an encouraging yearly guidance.
DocuSign (DOCU) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DocuSign's (DOCU) first-quarter fiscal 2022 earnings are expected to have benefited from improvement in operational efficiency.
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Consecutive better-than-expected top- and bottom-line performances, along with an encouraging yearly guidance, have been aiding IQVIA Holdings (IQV) stock.
Here is Why Growth Investors Should Buy IQVIA (IQV) Now
by Zacks Equity Research
IQVIA (IQV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ExlService Holdings (EXLS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
ExlService Holdings (EXLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What Awaits Opendoor Technologies (OPEN) in Q1 Earnings?
by Zacks Equity Research
Opendoor Technologies' (OPEN) first-quarter 2021 revenues are expected to have benefited from solid home resale performance and an increase in home purchases
3 Reasons Why Growth Investors Shouldn't Overlook IQVIA (IQV)
by Zacks Equity Research
IQVIA (IQV) could produce exceptional returns because of its solid growth attributes.
Interpublic (IPG) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Interpublic (IPG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ICF (ICFI) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
ICF (ICFI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IQVIA (IQV) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IQVIA (IQV) Beats on Q1 Earnings & Revenues, Raises 2021 View
by Zacks Equity Research
IQVIA's (IQV) first-quarter 2021 earnings and revenues increase year over year.
IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 17.84% and 7.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for IQVIA Holdings (IQV) in Q1 Earnings?
by Zacks Equity Research
IQVIA's (IQV) first-quarter 2021 earnings and revenues are expected to have improved year over year.
ExlService Holdings (EXLS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
ExlService Holdings (EXLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
IQVIA Holdings (IQV) has been benefiting from consecutive better-than-expected top- and bottom-line performances, and encouraging yearly EPS guidance.
IQVIA (IQV) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IQVIA (IQV) Buys Remaining Q2 Solutions Stake, Ups EPS View
by Zacks Equity Research
The latest deal is expected to help IQVIA (IQV) strengthen its Research & Development Solutions segment.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
by Zacks Equity Research
IQVIA Holdings (IQV) rises on consistent shareholder-friendly measures and strong healthcare-specific infrastructures. Meanwhile,the company's debt-laden balance sheet is a concern.
Why Is IQVIA (IQV) Down 1.8% Since Last Earnings Report?
by Zacks Equity Research
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IQVIA (IQV) Rides on Life Sciences Strength, Debt Woes Stay
by Zacks Equity Research
IQVIA (IQV) has a strong healthcare-specific global IT infrastructure, analytics-driven clinical development capabilities and a robust real-world solutions ecosystem.
IQVIA (IQV) Beats on Q4 Earnings & Revenues, Raises 2021 View
by Zacks Equity Research
IQVIA's (IQV) fourth-quarter 2020 revenues and earnings increase year over year.
IQVIA Holdings (IQV) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
IQVIA (IQV) delivered earnings and revenue surprises of 4.98% and 4.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Business Services Stocks Feb 10 Earnings Roster: IPG, WU and More
by Shuvra Shankar Dey
Here's a sneak peek of how Interpublic (IPG), Western Union (WU), IQVIA (IQV), Equifax (EFX) and Lumen Technologies (LUMN) are placed prior to their Feb 10 earnings releases.
What's in Store for IQVIA Holdings (IQV) in Q4 Earnings?
by Zacks Equity Research
IQVIA's (IQV) fourth-quarter 2020 earnings and revenues are expected to have improved year over year.